as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
0.34%
Downside
5.94%
Upside
52 Week's Low
52 Week's High
25.32%
Downside
83.19%
Upside
Check Integra Lifesciences Holdings Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.2B
EPS (TTM)
2.2125
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
67.94
Industry PE ratio
-3.9281873111782475
P/B Ratio
0PEG Ratio
0.7566
EBITDA
305.8M
Revenue (TTM)
1.6B
Profit Margin
-30.87%
Return On Equity TTM
316088100.00%
Track how Integra Lifesciences Holdings Corp P/E has moved over time to understand its valuation trends.
Integra Lifesciences Holdings Corp in the last 5 years
Lowest (8.53x)
December 31, 2024
Industry (-3.93x)
September 17, 2025
Today (67.94x)
September 17, 2025
Highest (25.47x)
March 31, 2021
Today’s Price to Earnings Ratio: 67.94x
Compare market cap, revenue, PE, and other key metrics of Integra Lifesciences Holdings Corp with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $1.2B | -68.14% | 67.94 | -30.87% | |
BUY | $146.7B | 149.51% | 58.92 | 13.55% | |
BUY | $144.0B | 78.01% | 50.02 | 12.25% | |
BUY | $231.1B | 24.47% | 16.66 | 32.43% | |
BUY | $120.8B | -12.63% | 26.02 | 13.63% |
The Integra Lifesciences Holdings Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Integra Lifesciences Holdings Corp investment value today
Current value as on today
₹90,904
Returns
Returns from Integra Lifesciences Holdings Corp Stock
Dollar Returns*
₹4,598 (+4.6%)
Based on 20 analysts
50.00%
Buy
35.00%
Hold
15.00%
Sell
Based on 20 analysts, 50% of analysts recommend a 'BUY' rating for Integra Lifesciences Holdings Corp. Average target price of $15.88
Get share price movements and forecasts by analysts on Integra Lifesciences Holdings Corp.
What analysts predicted
6.74%UPSIDE
Target Price
$15.88
Current Price
$14.81
Analyzed by
20 Analysts
Target
$15.88
Integra Lifesciences Holdings Corp target price $15.88, a slight upside of 6.74% compared to current price of $14.81. According to 20 analysts rating.
Search interest for Integra Lifesciences Holdings Corp Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:100% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 382.65M → 415.60M (in $), with an average increase of 7.9% per quarter
Against Peers
In the last 3 years, Boston Scientific Corp. has given 137.4% return, outperforming this stock by 204.8%
Against Peers
In the last 1 year, Boston Scientific Corp. has given 19.9% return, outperforming this stock by 33.5%
Price Dip
In the last 6 months, IART stock has moved down by -35.9%
Profit Down
Netprofit is down for the last 3 quarters, 19.43M → -484.07M (in $), with an average decrease of 1022.0% per quarter
Organisation | Integra Lifesciences Holdings Corp |
Headquarters | 1100 Campus Road, Princeton, NJ, United States, 08540 |
Industry | Health Technology |
CEO | Ms. Mojdeh Poul |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Lea Daniels Knight | Executive VP & CFO |
Mr. Robert T. Davis Jr. | Executive VP & President of Tissue Technologies |
Mr. Michael J. McBreen | Executive VP & President of Codman Specialty Surgical |
Mr. Harvinder Pal Singh | Executive VP & President of International Business |
Mr. Jeffrey A. Mosebrook | Senior VP of Finance & Principal Accounting Officer |
Dr. Stuart M. Essig Ph.D. | Non- Executive Chairman |
Mr. Stephen Leonard | Corporate VP of Global Operations & Supply Chain |
Christopher Ward | Senior Director of Investor Relations |
Laurene Isip | Vice President of Global Corporate Communications & Public Relations |
Ms. Mojdeh Poul | President, CEO & Director |
Integra Lifesciences Holdings Corp share price today is $14.81 as on at the close of the market. Integra Lifesciences Holdings Corp share today touched a day high of $15.69 and a low of $14.76.
Integra Lifesciences Holdings Corp share touched a 52 week high of $27.13 on and a 52 week low of $11.06 on . Integra Lifesciences Holdings Corp stock price today i.e. is closed at $14.81,which is 45.41% down from its 52 week high and 33.91% up from its 52 week low.
Integra Lifesciences Holdings Corp market capitalisation is $0.00T as on .
Indian investors can start investing in Integra Lifesciences Holdings Corp (IART) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Integra Lifesciences Holdings Corp stock (as per the Rupee-Dollar exchange rate as on ).
Based on Integra Lifesciences Holdings Corp share’s latest price of $14.81 as on September 18, 2025 at 1:29 am IST, you will get 0.6752 shares of Integra Lifesciences Holdings Corp. Learn more about
fractional shares .
Integra Lifesciences Holdings Corp stock has given -68.14% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?